1-乙基-3-(4-氟苯基)硫脲 | 61449-56-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-乙基-3-(4-氟苯基)硫脲
• 英文名称: 1-ethyl-3-(4-fluorophenyl)thiourea
• 英文别名: N-ethyl-N'-(4-fluorophenyl) thiourea；N-Aethyl-N'-p-fluorphenylthioharnstoff
• CAS: 61449-56-7
• 化学式: C₉H₁₁FN₂S
• mdl: MFCD02755719
• 分子量: 198.264
• InChiKey: XRVNUUHZOBJAQT-UHFFFAOYSA-N

物化性质

• 熔点：
  81-82 °C(Solv: ethanol (64-17-5))
• 沸点：
  263.7±42.0 °C(Predicted)
• 密度：
  1.239±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  56.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-甲基苯基)吡咯烷-2,5-二酮 、 1-乙基-3-(4-氟苯基)硫脲 以 异丙醇 为溶剂， 以75%的产率得到
  参考文献：
  名称：

  Synthesis of thiazolidines via regioselective addition of unsymmetric thioureas to maleic acid derivatives

  摘要：

  未对称硫脲与马来酸衍生物之间反应的区域选择性已经被研究，并建立了一般规律。

  DOI：

  10.1039/c4ra07840c
• 作为产物：
  描述：

  异硫氰酸乙酯 、 4-氟苯胺 以 乙醇 为溶剂， 生成 1-乙基-3-(4-氟苯基)硫脲
  参考文献：
  名称：

  Synthesis of thiazolidines via regioselective addition of unsymmetric thioureas to maleic acid derivatives

  摘要：

  未对称硫脲与马来酸衍生物之间反应的区域选择性已经被研究，并建立了一般规律。

  DOI：

  10.1039/c4ra07840c

文献信息

• 1,3-Disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
  申请人：Wyeth

  公开号：US20030119889A1

  公开（公告）日：2003-06-26

  Antiatherosclerotic compounds of Formula I are provided: 1 wherein: R is lower alkyl, alkenyl, alkynyl, or —O—(CH 2 ) n —COOR′; R′ is lower alkyl; n is an integer of 1-3; Ar is phenyl, or phenyl substituted with one or more of halogen, lower alkyl, alkenyl, alkynyl, alkoxy, perfluoroalkyl, perfluoroalkoxy, or alkylthio; and pharmaceutically acceptable salts thereof.

  提供了化学式I的抗动脉粥样硬化化合物： 其中： R为较低的烷基，烯基，炔基，或—O—(CH 2 ) n —COOR′; R′为较低的烷基; n为1-3的整数; Ar为苯基，或苯基上取代一个或多个卤素，较低的烷基，烯基，炔基，烷氧基，全氟烷基，全氟烷氧基，或烷基硫基;以及 其药用可接受盐。
• METHODS OF DEGRADING ORGANIC POLLUTANTS AND PREVENTING OR TREATING MICROBE USING Bi2S3-CdS PARTICLES
  申请人：Imam Abdulrahman Bin Faisal University

  公开号：US20200102228A1

  公开（公告）日：2020-04-02

  Methods of synthesizing Bi 2 S 3 —CdS particles in the form of spheres as well as properties of these Bi 2 S 3 —CdS particles are described. Methods of photocatalytic degradation of organic pollutants employing these Bi 2 S 3 —CdS particles and methods of preventing or reducing microbial growth on a surface by applying these Bi 2 S 3 —CdS particles in the form of a solution or an antimicrobial product onto the surface are also specified.

  本文描述了合成球形Bi2S3-CdS颗粒的方法以及这些颗粒的性质。还介绍了利用这些Bi2S3-CdS颗粒进行光催化降解有机污染物的方法，以及通过将这些Bi2S3-CdS颗粒以溶液或抗微生物产品的形式涂布在表面上来防止或减少微生物生长的方法。
• 1,3-disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
  申请人：Wyeth

  公开号：US07135492B2

  公开（公告）日：2006-11-14

  Antiatherosclerotic compounds of Formula I are provided: wherein: R is lower alkyl, alkenyl, alkynyl, or —O—(CH2)n—COOR′; R′ is lower alkyl; n is an integer of 1–3; Ar is phenyl, or phenyl substituted with one or more of halogen, lower alkyl, alkenyl, alkynyl, alkoxy, perfluoroalkyl, perfluoroalkoxy, or alkylthio; and pharmaceutically acceptable salts thereof.

  提供了公式I的抗动脉粥样硬化化合物： 其中： R是低烷基，烯基，炔基或—O—（CH2）n—COOR′; R′是低烷基; n为1-3的整数; Ar是苯基，或苯基上带有卤素，低烷基，烯基，炔基，烷氧基，全氟烷基，全氟烷氧基或烷基硫基;以及其药学上可接受的盐。
• Methods of degrading organic pollutants and preventing or treating microbe using Bi2S3-CdS particles
  申请人：Imam Abdulrahman Bin Faisal University

  公开号：US10934176B2

  公开（公告）日：2021-03-02

  Methods of synthesizing Bi2S3—CdS particles in the form of spheres as well as properties of these Bi2S3—CdS particles are described. Methods of photocatalytic degradation of organic pollutants employing these Bi2S3—CdS particles and methods of preventing or reducing microbial growth on a surface by applying these Bi2S3—CdS particles in the form of a solution or an antimicrobial product onto the surface are also specified.

  描述了合成球状 Bi2S3-CdS 颗粒的方法以及这些 Bi2S3-CdS 颗粒的特性。此外，还说明了利用这些 Bi2S3-CdS 颗粒光催化降解有机污染物的方法，以及通过将这些溶液形式的 Bi2S3-CdS 颗粒或抗菌产品涂抹到表面，防止或减少表面微生物生长的方法。
• Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties
  作者：Hassan Elokdah、Theodore S. Sulkowski、Magid Abou-Gharbia、John A. Butera、Sie-Yearl Chai、Geraldine R. McFarlane、Mar-Lee McKean、John L. Babiak、Steven J. Adelman、Elaine M. Quinet

  DOI：10.1021/jm030219z

  日期：2004.1.1

  A novel series of substituted sulfanyldihydroimidazolones (1) that modulates high-density lipoprotein cholesterol (HDL-C) has been reported to have HDL-elevating properties in several animal models. Concerns about the chemical and metabolic stability of I directed us to explore the structure-activity relationship (SAR) of a related series of substituted thiohydantoins (2). Expansion of the scope of the thiohydantoin series led to exploration of compounds in related thio-containing ring systems 3-7 and the N-cyanoguanidine derivative 8. Compounds were tested sequentially in three animal models to assess their HDL-C elevating efficacy and safety profiles. Further evaluation of selected compounds in a dose-response paradigm culminated in the identification of compound 2.39 as a candidate compound for advanced preclinical. studies.